Literature DB >> 29033050

Temporal Trends in the Incidence, Prevalence, and Survival of Patients With Atrial Fibrillation From 2004 to 2016.

Brent A Williams1, Ashley M Honushefsky2, Peter B Berger3.   

Abstract

A growing epidemic of atrial fibrillation (AF) has been predicted, although no data on the AF burden has been reported for the United States since 2010. The objectives of this study were to (1) describe trends in AF incidence, prevalence, and postdiagnosis survival from 2004 to 2016 within a large health-care system and (2) extrapolate observed prevalence rates to the entire US population to estimate the national AF burden. This retrospective cohort study incorporates the patients and electronic medical record of the Geisinger Health System, an integrated health-care delivery system serving central and northeast Pennsylvania. Standardized incidence rates were calculated per 1,000 person-years by calendar year, and point prevalence rates estimated on July 1st of the respective years from 2004 to 2016. Rate ratios were estimated from Poisson regression as the annual relative change over time. A total of 464,363 patients met study inclusion criteria. Age- and sex-adjusted AF incidence rates increased over the study period: 4.7, 5.0, 5.8, and 6.2 in 2004, 2008, 2012, and 2016, respectively (rate ratio 1.03 per year, 95% confidence interval 1.02, 1.03). Age- and sex-adjusted prevalence rates increased consistently over time from 2.7%, 3.0%, 3.4%, to 4.1% in 2004, 2008, 2012, and 2016, respectively. In 2004, an estimated 6.1 million Americans had diagnosed AF, increasing to 6.7, 7.8, and 9.3 million in 2008, 2012, and 2016, respectively. Postdiagnosis survival has not improved in recent years. In conclusion, AF incidence and prevalence have increased steadily since 2004, whereas postdiagnosis survival has not improved.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29033050     DOI: 10.1016/j.amjcard.2017.08.014

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

1.  Vaccination and risk of lone atrial fibrillation in the active component United States military.

Authors:  Michael M McNeil; Susan K Duderstadt; Jennifer F Sabatier; Gina G Ma; Jonathan Duffy
Journal:  Hum Vaccin Immunother       Date:  2019-01-08       Impact factor: 3.452

Review 2.  Shared decision-making in atrial fibrillation: navigating complex issues in partnership with the patient.

Authors:  Peter A Noseworthy; Juan P Brito; Marleen Kunneman; Ian G Hargraves; Claudia Zeballos-Palacios; Victor M Montori; Henry H Ting
Journal:  J Interv Card Electrophysiol       Date:  2018-10-17       Impact factor: 1.900

3.  Association between concurrent use of diltiazem and DOACs and risk of bleeding in atrial fibrillation patients.

Authors:  Mohammed Shurrab; Cynthia A Jackevicius; Peter C Austin; Karen Tu; Feng Qiu; Joseph Caswell; Faith Michael; Jason G Andrade; Dennis T Ko
Journal:  J Interv Card Electrophysiol       Date:  2022-09-23       Impact factor: 1.759

4.  Temporal Trends for Patients Hospitalized With Atrial Fibrillation in the United States: An Analysis From the National Inpatient Sample (NIS) Database 2011-2018.

Authors:  Brian Foster; Adnan Liaqat; Awais Farooq; Sagar Kulkarni; Saikiran Mandyam; Pooja Patak; Mo Zaman; Paramjit Kaur; Sebastian Tosto; Arthur Kendig
Journal:  Cureus       Date:  2022-06-06

5.  Prescribing of two potentially interacting cardiovascular medications in atrial fibrillation patients on direct oral anticoagulants.

Authors:  Mohammed Shurrab; Maria Koh; Cynthia A Jackevicius; Feng Qiu; Michael Conlon; Joseph Caswell; Karen Tu; Peter C Austin; Dennis T Ko
Journal:  Int J Cardiol Heart Vasc       Date:  2021-04-29

6.  Establishing a National Cardiovascular Disease Surveillance System in the United States Using Electronic Health Record Data: Key Strengths and Limitations.

Authors:  Brent A Williams; Stephen Voyce; Stephen Sidney; Véronique L Roger; Timothy B Plante; Sharon Larson; Michael J LaMonte; Darwin R Labarthe; Bailey M DeBarmore; Alexander R Chang; Alanna M Chamberlain; Catherine P Benziger
Journal:  J Am Heart Assoc       Date:  2022-04-12       Impact factor: 6.106

7.  Deep Learning Approaches to Detect Atrial Fibrillation Using Photoplethysmographic Signals: Algorithms Development Study.

Authors:  Soonil Kwon; Joonki Hong; Eue-Keun Choi; Euijae Lee; David Earl Hostallero; Wan Ju Kang; Byunghwan Lee; Eui-Rim Jeong; Bon-Kwon Koo; Seil Oh; Yung Yi
Journal:  JMIR Mhealth Uhealth       Date:  2019-06-06       Impact factor: 4.773

Review 8.  Mortality in atrial fibrillation. Is it changing?

Authors:  Alvaro Alonso; Zakaria Almuwaqqat; Alanna Chamberlain
Journal:  Trends Cardiovasc Med       Date:  2020-10-27       Impact factor: 6.677

9.  Trends in Atrial Fibrillation Incidence Rates Within an Integrated Health Care Delivery System, 2006 to 2018.

Authors:  Brent A Williams; Alanna M Chamberlain; James C Blankenship; Elaine M Hylek; Stephen Voyce
Journal:  JAMA Netw Open       Date:  2020-08-03

10.  In-Vitro Sorbent-Mediated Removal of Edoxaban from Human Plasma and Albumin Solution.

Authors:  Alexandra A Angheloiu; Yanglan Tan; Cristian Ruse; Scott A Shaffer; George O Angheloiu
Journal:  Drugs R D       Date:  2020-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.